Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Long-Term Investments (2024 - 2025)

Historic Long-Term Investments for Outlook Therapeutics (OTLK) over the last 2 years, with Q4 2025 value amounting to $513549.0.

  • Outlook Therapeutics' Long-Term Investments fell 2217.72% to $513549.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $513549.0, marking a year-over-year decrease of 2217.72%. This contributed to the annual value of $552183.0 for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Outlook Therapeutics' Long-Term Investments stood at $513549.0, which was down 2217.72% from $552183.0 recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Long-Term Investments registered a high of $659895.0 during Q4 2024, and its lowest value of $513549.0 during Q4 2025.